ClinConnect ClinConnect Logo
Search / Trial NCT06316635

Microplastics in Otitis Media With Effusion Material

Launched by KEREM KÖKOĞLU · Mar 14, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Microplastics Hearing Loss Otitis Media Biofilm Air Pollution

ClinConnect Summary

This clinical trial is studying the presence of microplastics in the fluid of the middle ear in patients with a condition called otitis media with effusion (OME). OME is a common ear problem in children that involves fluid buildup behind the eardrum, which can lead to hearing issues and other complications. Researchers are concerned that microplastics, tiny pieces of plastic found in our environment, might contribute to this condition by interacting with biofilms—collections of bacteria that can form in the ear.

The trial is currently looking for participants aged between 6 months to 74 years who have been experiencing OME for at least three months on both sides or nine months on one side. However, individuals with certain conditions, like craniofacial anomalies or those who've had previous ear surgeries, cannot join the study. If you or someone you know qualifies and decides to participate, you can expect to provide a sample of ear fluid for testing, which will help researchers understand the potential link between microplastics and ear health. This study is important for uncovering how environmental factors might affect children's health, particularly regarding ear infections.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients who were followed by bilateral OME at least for three months or one-sided OME at least for 9 months were enrolled to the study
  • Exclusion Criteria:
  • Patients with craniofacial anomaly, cleft palate, had history of previous ear surgery were excluded

About Kerem Kökoğlu

Kerem Kökoğlu is a dedicated clinical trial sponsor with a focus on advancing innovative medical research and improving patient outcomes. With a commitment to ethical practices and rigorous scientific standards, Kökoğlu oversees a range of clinical studies aimed at developing new therapies and enhancing existing treatments. His extensive experience in the clinical research landscape, coupled with a strong network of healthcare professionals and research institutions, enables him to drive projects from conception through to successful completion. By prioritizing collaboration and transparency, Kerem Kökoğlu aims to contribute significantly to the advancement of medical science and the well-being of patients worldwide.

Locations

Kayseri, , Turkey

Patients applied

0 patients applied

Trial Officials

Mehmet I Şahin, Assoc Prof.

Principal Investigator

TC Erciyes University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported